Johnson Anne Nagengast
CIK 0001976640
Chief Financial Officer
Filings
7
Latest Feb 3, 2026
Issuers covered
2
Showing
7 of 7
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | -5.9% | -5.9% | +2.1% | -13.9% |
| 90 days | 2 | 50% | -21.6% | -21.6% | +27.8% | -71.0% |
| 180 days | 2 | 50% | -90.0% | -90.0% | +38.0% | -217.9% |
| 365 days | 2 | 50% | -56.5% | -56.5% | +20.9% | -133.8% |
Issuers
Companies where Johnson Anne Nagengast has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ATAI | Atai Life Sciences N.V. | 6 | Mar 24, 2025 |
| ATAI | Ataibeckley Inc. | 1 | Feb 3, 2026 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|